Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.
Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus.
Reduced Dual-Task Performance in MS Patients Is Further Decreased by Muscle Fatigue.
Chromatic visual evoked potentials in young patients with demyelinating disease.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis.
Diffusion-weighted imaging using readout-segmented echo-planar imaging, parallel imaging, and two-dimensional navigator-based reacquisition in detecting acute optic neuritis.
Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data.
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV.
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.
Slowed Exercise-Onset Vo2 Kinetics During Submaximal Endurance Exercise in Subjects With Multiple Sclerosis.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
EDSS variability before randomization may limit treatment discovery in primary progressive MS.
Human Wharton?s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis.
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.
Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells.
[Present and future of the transcranial magnetic stimulation].
Management of disease modifying treatments in neurological autoimmune diseases of the central nervous system.
[Registries for neurological drugs landscape].
Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease.

Pages